SCHEMBL7385035

SCHEMBL7385035

[CH2]c1cccc(OCC(=O)OC(C)(C)C)c1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSEN1 P49768 2/20 0.45
PSEN2 P49810 2/20 0.45
APH1B Q8WW43 2/20 0.45
NCSTN Q92542 2/20 0.45
APH1A Q96BI3 2/20 0.45
PSENEN Q9NZ42 2/20 0.45
GAA P10253 1/20 0.43
LMNA P02545 2/20 0.43
MAPT P10636 2/20 0.43
POLB P06746 2/20 0.43
CYP2C9 P11712 2/20 0.43
CYP2C19 P33261 2/20 0.43
HPGD P15428 1/20 0.43
NPSR1 Q6W5P4 1/20 0.43
PTPN1 P18031 1/20 0.41
SYK P43405 1/20 0.41
ATM Q13315 1/20 0.40
DDB1 Q16531 1/20 0.40
CRBN Q96SW2 1/20 0.40
OPRK1 P41145 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17024452 0.89 LMNA (0.53) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL30737444 0.84 LMNA (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7385040 0.83 GAA (0.62) GAALMNAMAPTPOLBHPGD
SCHEMBL23523217 0.83 ALDH1A1 (0.53) GAALMNACYP2C9CYP2C19ALDH1A1
SCHEMBL2838476 0.82 CYP3A4 (0.51) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL14501385 0.82 PSEN1 (0.45) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL7110609 0.82 HSD17B10 (0.52) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL410069 0.81 PSEN1 (0.42) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6708174 0.81 PTPN1 (0.50) PSEN1PSEN2APH1BNCSTNAPH1A
SCHEMBL6216172 0.81 TSHR (0.49) PSEN1PSEN2APH1BNCSTNAPH1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6420418-B1 INHIBITION AND PREVENTION OF LEUKOCYTE ADHESION; USED TO TREAT ADHESION-MEDIATED DISEASES SUCH AS ASTHMA, ALLERGIC RHINITIS, MULTIPLE SCLEROSIS; ATHEROSCLEROSIS, AND INFLAMMATORY BOWEL DISEASE MERCK & CO., INC. 2002-07-16 US disclosed
WO-2001012183-A1 HETEROCYCLE AMIDES AS CELL ADHESION INHIBITORS MERCK & CO., INC. (US) 2001-02-22 WO disclosed